PLA2G12B and atherosclerosis: Finally, we evaluated the physiological consequences of PLA2G12B disruption, showing that Pla2g12bhlb218 mutants exhibit profound hypolipidemia and resistance to atherosclerosis coupled with otherwise normal growth and metabolism (Fig. 5).